Absci Corporation (ABSI) DCF Valuation

Absci Corporation (ABSI) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Absci Corporation (ABSI) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our (ABSI) DCF Calculator enables you to evaluate Absci Corporation's valuation using real-world financial data, while offering complete flexibility to modify all essential parameters for improved projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 2.1 4.8 4.8 5.7 5.7 7.4 9.7 12.5 16.3 21.2
Revenue Growth, % 0 132.04 0.041841 20.18 -0.50461 29.93 29.93 29.93 29.93 29.93
EBITDA -5.8 -12.6 -99.8 -91.4 -95.5 -7.4 -9.7 -12.5 -16.3 -21.2
EBITDA, % -282.77 -263.35 -2086.43 -1589.63 -1669.41 -100 -100 -100 -100 -100
Depreciation .5 1.1 6.7 13.0 14.0 5.2 6.7 8.7 11.3 14.7
Depreciation, % 23.83 23.66 139.15 226.85 244.82 69.5 69.5 69.5 69.5 69.5
EBIT -6.3 -13.7 -106.4 -104.4 -109.5 -7.4 -9.7 -12.5 -16.3 -21.2
EBIT, % -306.6 -287.01 -2225.58 -1816.48 -1914.24 -100 -100 -100 -100 -100
Total Cash 13.1 69.9 252.6 164.4 97.7 7.4 9.7 12.5 16.3 21.2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .2 1.6 1.4 1.6 2.2
Account Receivables, % 10.78 33.35 29.8 26.97 38.28
Inventories .0 .0 10.5 15.0 .0 3.0 3.9 5.0 6.5 8.5
Inventories, % 0.000048543689 0.000020920502 219.85 261.41 0 40 40 40 40 40
Accounts Payable .3 2.1 8.4 2.4 1.5 3.4 4.4 5.7 7.4 9.6
Accounts Payable, % 13.01 44.27 175.35 41.97 26.29 45.11 45.11 45.11 45.11 45.11
Capital Expenditure -1.1 -2.2 -38.0 -16.2 -.9 -4.7 -6.1 -7.9 -10.2 -13.3
Capital Expenditure, % -53.3 -45.63 -795.63 -281.45 -15.04 -62.79 -62.79 -62.79 -62.79 -62.79
Tax Rate, % -0.09052559 -0.09052559 -0.09052559 -0.09052559 -0.09052559 -0.09052559 -0.09052559 -0.09052559 -0.09052559 -0.09052559
EBITAT -6.5 -13.9 -97.8 -103.9 -109.6 -7.3 -9.5 -12.3 -16.0 -20.8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -7.1 -14.5 -133.3 -117.7 -82.9 -7.8 -9.3 -12.1 -15.8 -20.5
WACC, % 14.28 14.28 14.25 14.27 14.28 14.27 14.27 14.27 14.27 14.27
PV UFCF
SUM PV UFCF -41.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -21
Terminal Value -170
Present Terminal Value -87
Enterprise Value -129
Net Debt -56
Equity Value -73
Diluted Shares Outstanding, MM 92
Equity Value Per Share -0.79

What You Will Receive

  • Adjustable Forecast Parameters: Modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Actual Market Data: Absci Corporation’s financial figures pre-loaded to facilitate your analysis.
  • Instant DCF Calculations: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Tailored and Professional: A refined Excel model that aligns with your valuation requirements.
  • Designed for Analysts and Investors: Perfect for assessing projections, validating strategies, and enhancing efficiency.

Key Features

  • Customizable Forecast Inputs: Adjust essential factors such as revenue growth, gross margin %, and research & development expenses.
  • Instant DCF Valuation: Automatically computes intrinsic value, net present value (NPV), and additional metrics without delay.
  • High-Precision Accuracy: Incorporates Absci Corporation's (ABSI) actual financial data for reliable valuation results.
  • Effortless Scenario Analysis: Evaluate various assumptions and analyze results with ease.
  • Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Absci Corporation’s (ABSI) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including Absci Corporation’s (ABSI) intrinsic value.
  • Step 5: Make well-informed investment choices or create reports based on the outputs.

Why Choose This Calculator for Absci Corporation (ABSI)?

  • All-in-One Solution: Offers DCF, WACC, and financial ratio analyses tailored for Absci Corporation.
  • Adjustable Parameters: Modify yellow-highlighted fields to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes Absci’s intrinsic value and Net Present Value.
  • Preloaded Information: Includes historical and projected data for precise calculations.
  • Expert-Level Tool: Perfect for financial analysts, investors, and business consultants focusing on Absci Corporation.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for assessing Absci Corporation (ABSI) investments.
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in Absci Corporation (ABSI) stock.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech firms like Absci Corporation (ABSI) are valued in the investment landscape.

What the Template Contains

  • Pre-Filled DCF Model: Absci Corporation’s (ABSI) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Absci Corporation’s (ABSI) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.